Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Allopurinol, and when can generics launch?

Allopurinol is a drug marketed by Watson Labs, Ipca Labs Ltd, Puracap Pharm, Mutual Pharm, Sun Pharm Inds, Superpharm, Apotex Inc, Northstar Hlthcare, Accord Hlthcare, Mylan, Indoco Remedies, Sandoz, Purepac Pharm, Sun Pharm Inds Inc, Vintage Pharms, and West-ward Pharms Int. and is included in twenty-five NDAs.

The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.

Summary for Tradename: ALLOPURINOL

Suppliers / Packagers: see list41
Bulk Api Vendors: see list151
Clinical Trials: see list44
Patent Applications: see list5,551
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALLOPURINOL at DailyMed

Pharmacology for Tradename: ALLOPURINOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
TABLET;ORAL078390-002Aug 30, 2007ABRXNoNo► Subscribe► Subscribe
Purepac Pharm
TABLET;ORAL070580-001Apr 14, 1986DISCNNoNo► Subscribe► Subscribe
Vintage Pharms
TABLET;ORAL075798-001Jun 27, 2003ABRXNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL018785-001Sep 28, 1984DISCNNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL018832-002Sep 28, 1984ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus